Literature DB >> 26022955

Criteria for diagnosis of exercise pulmonary hypertension.

Philippe Herve1, Edmund M Lau2, Olivier Sitbon3, Laurent Savale4, David Montani3, Laurent Godinas4, Frederic Lador5, Xavier Jaïs4, Florence Parent4, Sven Günther4, Marc Humbert3, Gerald Simonneau3, Denis Chemla6.   

Abstract

The previous definition of exercise pulmonary hypertension (PH) with a mean pulmonary artery pressure (mPAP) >30 mmHg was abandoned because healthy individuals can exceed this threshold at high cardiac output (CO). We hypothesised that incorporating assessment of the pressure-flow relationship using the mPAP/CO ratio, i.e. total pulmonary resistance (TPR), might enhance the accuracy of diagnosing an abnormal exercise haemodynamic response.Exercise haemodynamics were evaluated in 169 consecutive subjects with normal resting mPAP ≤20 mmHg. Subjects were classified into controls without heart or lung disease (n=68) versus patients with pulmonary vascular disease (PVD) (n=49) and left heart disease (LHD) (n=52).TPR and mPAP at maximal exercise produced diagnostic accuracy with area under the receiver operating curve of 0.99 and 0.95, respectively, for discriminating controls versus patients with PVD and LHD. The old criterion of mPAP >30 mmHg had sensitivity of 0.98 but specificity of 0.77. Combining maximal mPAP >30 mmHg and TPR >3 mmHg·min·L(-1) retained sensitivity at 0.93 but improved specificity to 1.0. The accuracy of the combined criteria was high across different age groups, sex, body mass index and diagnosis (PVD or LHD).Combining mPAP >30 mmHg and TPR >3 mmHg·min·L(-1) is superior to mPAP >30 mmHg alone for defining a pathological haemodynamic response of the pulmonary circulation during exercise.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26022955     DOI: 10.1183/09031936.00021915

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  61 in total

Review 1.  Pulmonary Hypertension Due to Left Heart Disease: an Update.

Authors:  Mandar A Aras; Mitchell A Psotka; Teresa De Marco
Journal:  Curr Cardiol Rep       Date:  2019-05-27       Impact factor: 2.931

Review 2.  Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.

Authors:  Bradley A Maron; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

3.  Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Authors:  Thomas M Gorter; Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Barry A Borlaug
Journal:  Eur Heart J       Date:  2018-08-07       Impact factor: 29.983

4.  Hypertension: Definition of pulmonary hypertension challenged?

Authors:  Adam Torbicki
Journal:  Nat Rev Cardiol       Date:  2016-03-24       Impact factor: 32.419

Review 5.  Update in Pulmonary Vascular Disease 2015.

Authors:  Bradley A Maron; Mark T Gladwin; Marc A Simon
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

6.  Exercise Doppler echocardiography for the diagnosis of pulmonary hypertension: renewed interest and evolving roles.

Authors:  Yun Yun Go; Raluca Dulgheru; Tadafumi Sugimoto; Stella Marchetta; Cécile Oury; Patrizio Lancellotti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

7.  Assessment of pulmonary vascular response to exercise with Doppler-echocardiography: state of the art?

Authors:  Alberto M Marra; Ekkehard Grünig
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  Network Analysis to Risk Stratify Patients With Exercise Intolerance.

Authors:  William M Oldham; Rudolf K F Oliveira; Rui-Sheng Wang; Alexander R Opotowsky; David M Rubins; Jon Hainer; Bradley M Wertheim; George A Alba; Gaurav Choudhary; Adrienn Tornyos; Calum A MacRae; Joseph Loscalzo; Jane A Leopold; Aaron B Waxman; Horst Olschewski; Gabor Kovacs; David M Systrom; Bradley A Maron
Journal:  Circ Res       Date:  2018-02-05       Impact factor: 17.367

Review 9.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing.

Authors:  C Charles Jain; Barry A Borlaug
Journal:  Chest       Date:  2020-05-28       Impact factor: 9.410

10.  Pulmonary hemodynamics responses to hypoxia and/or CO2 inhalation during moderate exercise in humans.

Authors:  Stéphane Doutreleau; Irina Enache; Cristina Pistea; Bernard Geny; Anne Charloux
Journal:  Pflugers Arch       Date:  2018-03-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.